Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | pp65 Dendritic Cell Vaccine |
Trade Name | |
Synonyms | pp65 DC Vaccine |
Drug Descriptions |
Pp65 dendritic cell vaccine is a cancer vaccine composed of autologous dendritic cells modified to express pp65, which potentially results in increased immune response against pp65-expressing tumors (PMID: 25762141, PMID: 28411277). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C116740 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
pp65 Dendritic Cell Vaccine | pp65 Dendritic Cell Vaccine | 0 | 0 |
pp65 Dendritic Cell Vaccine + Sargramostim | Sargramostim pp65 Dendritic Cell Vaccine | 0 | 1 |
pp65 Dendritic Cell Vaccine + Temozolomide | Temozolomide pp65 Dendritic Cell Vaccine | 0 | 2 |
pp65 Dendritic Cell Vaccine + Temozolomide + Varlilumab | Temozolomide Varlilumab pp65 Dendritic Cell Vaccine | 0 | 1 |